Teva Pharmaceutical Industries
(NYSE: TEVA)
-0.16
-0.40%
Teva Pharmaceutical Industries, a large-cap value company in the health care sector, is expected to underperform the market over the next six months with less than average risk.
10 is the best possible rating.
The StockScouter measure of relative price change and consistency is low. Negative
One or more analysts has modestly decreased quarterly earnings estimates for TEVA. Negative
Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a large company like TEVA
The most recent quarterly earnings report was approximately equal to or higher than analysts’ consensus forecast, but not to a degree that is predictive of future returns. Neutral
Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
One or more analysts has modestly decreased quarterly earnings estimates for TEVA. Negative
Insider trading information is unavailable or inconsistent.
Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a large company like TEVA
The price-to-earnings multiple is close to the average for all stocks in the StockScouter universe. Neutral
The price-to-sales multiple is about the same as the average for all stocks in the StockScouter universe. Neutral for a medium- to large-sized company like TEVA
The ratio of TEVA's price-to-earnings multiple to its five-year growth rate is negative or below the average of all stocks in the StockScouter universe. Negative
The StockScouter measure of relative price change and consistency is low. Negative
Previous day's closing price for TEVA was close to its 50-day moving average. Neutral
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 6/19/2013 11:56 AM ET
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
